Achilles Therapeutics PL-ADRACHL
13F holders, Q1 2024 (March 31)32holders
3famous investors
$1.25avg. 13F price*
At the end of Q1 2024, 32 institutions reported holding Achilles Therapeutics PL-ADR (ACHL) in their 13F filings. The largest holders were Syncona Portfolio Ltd ($13.9M), FCPM III Services B.V. ($3.0M) and Redmile Group, LLC ($2.0M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Achilles Therapeutics PL-ADR
- CUSIP
- 00449L102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $4.6M |
| Exits | 1 | $1.3M |
Ownership 32 holders
| Syncona Portfolio Ltd | 9.24% | No change | 11,086,909 | $13.9M |
| FCPM III Services B.V. | 0.42% | No change | 2,390,050 | $3.0M |
| Redmile Group, LLC | 0.07% | No change | 1,608,089 | $2.0M |
| Vestal Point Capital, LP | 0.16% | Add +1287.8% | 1,500,000 | $1.9M |
| Ikarian Capital, LLC | 0.49% | New | 1,443,181 | $1.8M |
| Stempoint Capital LP | 0.46% | New | 1,385,750 | $1.7M |
| Baker Bros. Advisors LP | 0.02% | Reduce -42.5% | 1,208,775 | $1.5M |
| Renaissance Technologies | 0.00% | Add +101.6% | 1,005,759 | $1.3M |
| Artal Group S.A. | 0.02% | Reduce -66.5% | 755,375 | $944K |
| Boothbay Fund Management, LLC | 0.02% | New | 420,481 | $526K |
| Acadian Asset Management LLC | 0.00% | New | 280,929 | $350K |
| Citadel Advisors | 0.00% | Reduce -3.2% | 104,993 | $131K |
| Forefront Analytics, LLC | 0.06% | Add +25.1% | 95,445 | $119K |
| HRT Financial LP | 0.00% | New | 36,918 | $46K |
| Geode Capital Management, LLC | 0.00% | No change | 21,590 | $27K |
| Virtu Financial LLC | 0.00% | Reduce -47.1% | 20,947 | $26K |
| Millennium Management | 0.00% | Reduce -38.2% | 19,117 | $24K |
| Vontobel Holding Ltd. | 0.00% | New | 19,000 | $24K |
| Morgan Stanley | 0.00% | Add +90905.0% | 18,201 | $23K |
| Two Sigma Advisers, LP | 0.00% | New | 17,900 | $22K |
| Two Sigma Securities, LLC | 0.00% | Add +12.2% | 16,312 | $20K |
| XTX Topco Ltd | 0.00% | New | 15,219 | $19K |
| Two Sigma Investments, LP | 0.00% | New | 11,799 | $15K |
| OneDigital Investment Advisors LLC | 0.00% | New | 10,500 | $13K |
| Brave Asset Management Inc. | 0.00% | New | 10,000 | $13K |
| Rhumbline Advisers | 0.00% | New | 3,514 | $4K |
| Global Retirement Partners, LLC | 0.00% | Reduce -33.3% | 2,000 | $3K |
| Bank of America Corp. | 0.00% | Reduce -95.2% | 1,092 | $1K |
| ICA Group Wealth Management, LLC | 0.00% | New | 400 | $500 |
| JPMorgan Chase & Co. | 0.00% | Reduce -86.2% | 137 | $171 |
| Qube Research & Technologies Ltd | 0.00% | No change | 73 | $91 |
| Royal Bank of Canada | 0.00% | No change | 35 | $0 |
"% of holder's portfolio" is ACHL's weight in each manager's 13F, not the share of Achilles Therapeutics PL-ADR the manager owns.